VAERS reports by lot

GSK Varicella/Shingles lot N9CA2: VAERS reports

41 VAERS reports list lot N9CA2 as a GSK Varicella/Shingles vaccine, received between 2019-02-13 and 2019-09-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
41
Reports
7%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4329%
Injection-site / Local reaction2517%
Neurological2013%
Gastrointestinal1510%
Dermatological (non-injection-site)1510%
Cardiac / Cardiovascular128%
Musculoskeletal96%
Allergic / Anaphylactic75%
Respiratory43%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York7
Michigan3
Georgia3
Florida2
North Carolina2
Missouri2
Pennsylvania2
Minnesota2
Louisiana1
Alaska1
Colorado1
Washington1

Reports by month received

2019-028
2019-0315
2019-045
2019-059
2019-061
2019-072
2019-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.